Filing Details
- Accession Number:
- 0001209191-20-058274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-13 16:08:47
- Reporting Period:
- 2020-11-12
- Accepted Time:
- 2020-11-13 16:08:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750019 | Tcr2 Therapeutics Inc. | TCRR | Biological Products, (No Disgnostic Substances) (2836) | 474152751 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760102 | Robert Hofmeister | C/O Tcr2 Therapeutics 100 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-12 | 9,998 | $0.74 | 48,848 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-12 | 9,998 | $25.10 | 38,850 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-12 | 10,002 | $0.74 | 48,852 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-12 | 10,002 | $25.10 | 38,850 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-12 | 9,998 | $0.00 | 9,998 | $0.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-12 | 10,002 | $0.00 | 10,002 | $0.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,348 | 2018-12-07 | 2027-12-07 | No | 4 | M | Direct |
| 25,730 | 2017-12-13 | 2026-12-13 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- 25% of this option vested and become exercisable on December 7, 2018, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
- 25% of this option vested and become exercisable on December 13, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Billionaire Hedge Funds
